2024 年第 17 卷第 1 期 23 ORIGINAL RESEARCH IMMUNE STATUS CHARACTERISTICS OF GLOMERULONEPHRITIS PATIENTS WITH REFRACTORY NEPHROTIC SYNDROME 2024 年第 17 卷第 1 期 23 ORIGINAL RESEARCH IMMUNE STATUS CHARACTERISTICS OF GLOMERULONEPHRITIS PATIENTS WITH REFRACTORY NEPHROTIC SYNDROME

S. I. Kudryashov, Marina A. Stenina, L. M. Karzakova, Evgeniya V. Sokolova, I. A. Sidorov, L. V. Borisova, Tatyana R. Vozyakova
{"title":"2024 年第 17 卷第 1 期 23 ORIGINAL RESEARCH IMMUNE STATUS CHARACTERISTICS OF GLOMERULONEPHRITIS PATIENTS WITH REFRACTORY NEPHROTIC SYNDROME 2024 年第 17 卷第 1 期 23 ORIGINAL RESEARCH IMMUNE STATUS CHARACTERISTICS OF GLOMERULONEPHRITIS PATIENTS WITH REFRACTORY NEPHROTIC SYNDROME","authors":"S. I. Kudryashov, Marina A. Stenina, L. M. Karzakova, Evgeniya V. Sokolova, I. A. Sidorov, L. V. Borisova, Tatyana R. Vozyakova","doi":"10.20969/vskm.2024.17(1).22-28","DOIUrl":null,"url":null,"abstract":"Abstract. Introduction. Research in the issues related to glomerulonephritis with nephrotic syndrome is an important problem of modern medicine due to their prevalence among the global population and mainly in the younger age group, with a significant proportion of patients with refractory nephrotic syndrome (frequent relapses, persistent course). Currently, there are no ways to predict the development of glomerulonephrites with refractory nephrotic syndrome. Due to the immunological nature of glomerulonephrites, it seems advisable to search for predictors of refractory nephrotic syndrome among the indicators characterizing the patient’s immune status. Aim of the study was to study the characteristic features of the immune status and their prognostic value in glomerulonephritis with refractory nephrotic syndrome. Materials and Methods. We examined 136 glomerulonephritis patients with active nephrotic syndrome, hospitalized in the nephrology department in 2015-2021. Along with conventional examinations, humoral and T-cell immunity indicators were tested in the patients. The end point of the study was in 2022 where the the clinical course of the disease was assessed in patients, and patients with nephrotic syndrome who showed refractory to steroid therapy were placed into one group, while those with non–refractory nephrotic syndrome were placed into another one. Within the selected groups of patients, we performed the comparative study of demographic, clinical and laboratory parameters, the indicators of humoral and T-cell immunity, and the ROC analysis of indicators correlating with the nephrotic syndrome recurrence frequency. Results and Discussion. In the group of patients with a refractory course of the disease, an increase was detected in the number of T helper phenotype cells and of the activated T cells carrying activation markers, HLA-DR and CD38, on their surfaces. At the same time, the relative content of regulatory T cells (Treg) among T helper cells decreased. The B system was characterized by an increase in the number of B lymphocytes, an increase in the levels of circulating immune complexes and IgM, and a decrease in IgG levels. The changes detected in the parameters of humoral and T-cell immunity may be essential to the development of refractory nephrotic syndrome. In the refractory nephrotic syndrome pathogenesis, the most important is the decrease in the number of Tregs, which correlated most closely with the nephrotic syndrome recurrence frequency. Conclusions. An association was found between refractory nephrotic syndrome and the pronounced activation of humoral immunity, and a significant imbalance was detected between various immunoregulatory and activated T-lymphocyte subpopulations. The Treg content in the blood can be a prognostic indicator: Treg content values of under 1.9% indicate a high probability of developing refractory nephrotic syndrome.","PeriodicalId":110361,"journal":{"name":"The Bulletin of Contemporary Clinical Medicine","volume":"231 9","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"ВЕСТНИК СОВРЕМЕННОЙ КЛИНИЧЕСКОЙ МЕДИЦИНЫ 2024 Том 17, вып. 1 23ОРИГИНАЛЬНЫЕ ИССЛЕДОВАНИЯ IMMUNE STATUS CHARACTERISTICS OF GLOMERULONEPHRITIS PATIENTS WITH REFRACTORY NEPHROTIC SYNDROME\",\"authors\":\"S. I. Kudryashov, Marina A. Stenina, L. M. Karzakova, Evgeniya V. Sokolova, I. A. Sidorov, L. V. Borisova, Tatyana R. Vozyakova\",\"doi\":\"10.20969/vskm.2024.17(1).22-28\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Abstract. Introduction. Research in the issues related to glomerulonephritis with nephrotic syndrome is an important problem of modern medicine due to their prevalence among the global population and mainly in the younger age group, with a significant proportion of patients with refractory nephrotic syndrome (frequent relapses, persistent course). Currently, there are no ways to predict the development of glomerulonephrites with refractory nephrotic syndrome. Due to the immunological nature of glomerulonephrites, it seems advisable to search for predictors of refractory nephrotic syndrome among the indicators characterizing the patient’s immune status. Aim of the study was to study the characteristic features of the immune status and their prognostic value in glomerulonephritis with refractory nephrotic syndrome. Materials and Methods. We examined 136 glomerulonephritis patients with active nephrotic syndrome, hospitalized in the nephrology department in 2015-2021. Along with conventional examinations, humoral and T-cell immunity indicators were tested in the patients. The end point of the study was in 2022 where the the clinical course of the disease was assessed in patients, and patients with nephrotic syndrome who showed refractory to steroid therapy were placed into one group, while those with non–refractory nephrotic syndrome were placed into another one. Within the selected groups of patients, we performed the comparative study of demographic, clinical and laboratory parameters, the indicators of humoral and T-cell immunity, and the ROC analysis of indicators correlating with the nephrotic syndrome recurrence frequency. Results and Discussion. In the group of patients with a refractory course of the disease, an increase was detected in the number of T helper phenotype cells and of the activated T cells carrying activation markers, HLA-DR and CD38, on their surfaces. At the same time, the relative content of regulatory T cells (Treg) among T helper cells decreased. The B system was characterized by an increase in the number of B lymphocytes, an increase in the levels of circulating immune complexes and IgM, and a decrease in IgG levels. The changes detected in the parameters of humoral and T-cell immunity may be essential to the development of refractory nephrotic syndrome. In the refractory nephrotic syndrome pathogenesis, the most important is the decrease in the number of Tregs, which correlated most closely with the nephrotic syndrome recurrence frequency. Conclusions. An association was found between refractory nephrotic syndrome and the pronounced activation of humoral immunity, and a significant imbalance was detected between various immunoregulatory and activated T-lymphocyte subpopulations. The Treg content in the blood can be a prognostic indicator: Treg content values of under 1.9% indicate a high probability of developing refractory nephrotic syndrome.\",\"PeriodicalId\":110361,\"journal\":{\"name\":\"The Bulletin of Contemporary Clinical Medicine\",\"volume\":\"231 9\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-02-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"The Bulletin of Contemporary Clinical Medicine\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.20969/vskm.2024.17(1).22-28\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"The Bulletin of Contemporary Clinical Medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.20969/vskm.2024.17(1).22-28","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

摘要。引言。研究肾小球肾炎合并肾病综合征的相关问题是现代医学的一个重要问题,因为这种疾病在全球人口中普遍存在,而且主要发生在年轻群体中,难治性肾病综合征(经常复发、病程持续)患者所占比例很大。目前,还没有办法预测难治性肾病综合征肾小球肾炎的发生。鉴于肾小球肾炎的免疫学性质,似乎应该在描述患者免疫状态的指标中寻找难治性肾病综合征的预测因子。本研究旨在研究肾小球肾炎伴难治性肾病综合征患者免疫状态的特征及其预后价值。材料和方法。我们对2015-2021年肾内科住院的136名活动性肾病综合征肾小球肾炎患者进行了检查。除常规检查外,还对患者的体液免疫和T细胞免疫指标进行了检测。研究的终点是2022年,当时对患者的临床病程进行了评估,并将类固醇治疗难治性肾病综合征患者分为一组,将非难治性肾病综合征患者分为另一组。在选定的患者组中,我们对人口统计学、临床和实验室指标、体液免疫和T细胞免疫指标进行了比较研究,并对与肾病综合征复发频率相关的指标进行了ROC分析。结果与讨论在难治性肾病患者组中,发现 T 辅助表型细胞和表面携带活化标记 HLA-DR 和 CD38 的活化 T 细胞数量增加。同时,T 辅助细胞中调节性 T 细胞(Treg)的相对含量下降。B 系统的特点是 B 淋巴细胞数量增加,循环免疫复合物和 IgM 水平上升,IgG 水平下降。体液免疫和 T 细胞免疫参数的变化可能是难治性肾病综合征发病的关键。在难治性肾病综合征的发病机制中,最重要的是Tregs数量的减少,这与肾病综合征的复发频率密切相关。结论研究发现,难治性肾病综合征与体液免疫的明显激活有关,各种免疫调节和激活的T淋巴细胞亚群之间存在明显的不平衡。血液中的 Treg 含量可作为预后指标:Treg 含量值低于 1.9% 表明患难治性肾病综合征的可能性很高。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
ВЕСТНИК СОВРЕМЕННОЙ КЛИНИЧЕСКОЙ МЕДИЦИНЫ 2024 Том 17, вып. 1 23ОРИГИНАЛЬНЫЕ ИССЛЕДОВАНИЯ IMMUNE STATUS CHARACTERISTICS OF GLOMERULONEPHRITIS PATIENTS WITH REFRACTORY NEPHROTIC SYNDROME
Abstract. Introduction. Research in the issues related to glomerulonephritis with nephrotic syndrome is an important problem of modern medicine due to their prevalence among the global population and mainly in the younger age group, with a significant proportion of patients with refractory nephrotic syndrome (frequent relapses, persistent course). Currently, there are no ways to predict the development of glomerulonephrites with refractory nephrotic syndrome. Due to the immunological nature of glomerulonephrites, it seems advisable to search for predictors of refractory nephrotic syndrome among the indicators characterizing the patient’s immune status. Aim of the study was to study the characteristic features of the immune status and their prognostic value in glomerulonephritis with refractory nephrotic syndrome. Materials and Methods. We examined 136 glomerulonephritis patients with active nephrotic syndrome, hospitalized in the nephrology department in 2015-2021. Along with conventional examinations, humoral and T-cell immunity indicators were tested in the patients. The end point of the study was in 2022 where the the clinical course of the disease was assessed in patients, and patients with nephrotic syndrome who showed refractory to steroid therapy were placed into one group, while those with non–refractory nephrotic syndrome were placed into another one. Within the selected groups of patients, we performed the comparative study of demographic, clinical and laboratory parameters, the indicators of humoral and T-cell immunity, and the ROC analysis of indicators correlating with the nephrotic syndrome recurrence frequency. Results and Discussion. In the group of patients with a refractory course of the disease, an increase was detected in the number of T helper phenotype cells and of the activated T cells carrying activation markers, HLA-DR and CD38, on their surfaces. At the same time, the relative content of regulatory T cells (Treg) among T helper cells decreased. The B system was characterized by an increase in the number of B lymphocytes, an increase in the levels of circulating immune complexes and IgM, and a decrease in IgG levels. The changes detected in the parameters of humoral and T-cell immunity may be essential to the development of refractory nephrotic syndrome. In the refractory nephrotic syndrome pathogenesis, the most important is the decrease in the number of Tregs, which correlated most closely with the nephrotic syndrome recurrence frequency. Conclusions. An association was found between refractory nephrotic syndrome and the pronounced activation of humoral immunity, and a significant imbalance was detected between various immunoregulatory and activated T-lymphocyte subpopulations. The Treg content in the blood can be a prognostic indicator: Treg content values of under 1.9% indicate a high probability of developing refractory nephrotic syndrome.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信